Comment on

• Recent trends in U.S. breast cancer incidence, survival, and mortality rates.

  Chu KC, Tarone RE, Kessler LG, Ries LA, Hankey BF, Miller BA, Edwards BK. Chu KC, et al. J Natl Cancer Inst. 1996 Nov 6;88(21):1571-9. doi: 10.1093/jnci/88.21.1571. J Natl Cancer Inst. 1996. PMID: 8901855
• Postchemotherapy adjuvant tamoxifen therapy beyond five years in patients with lymph node-positive breast cancer. Eastern Cooperative Oncology Group.

  Tormey DC, Gray R, Falkson HC. Tormey DC, et al. J Natl Cancer Inst. 1996 Dec 18;88(24):1828-33. doi: 10.1093/jnci/88.24.1828. J Natl Cancer Inst. 1996. PMID: 8961972 Clinical Trial.
• Preliminary results from the cancer research campaign trial evaluating tamoxifen duration in women aged fifty years or older with breast cancer. Current Trials working Party of the Cancer Research Campaign Breast Cancer Trials Group.

  [No authors listed] [No authors listed] J Natl Cancer Inst. 1996 Dec 18;88(24):1834-9. doi: 10.1093/jnci/88.24.1834. J Natl Cancer Inst. 1996. PMID: 8961973 Clinical Trial.